BARKER, Timothy Hugh, Jennifer C STONE, Kim SEARS, Miloslav KLUGAR, Catalin TUFANARU, Jo LEONARDI-BEE, Edoardo AROMATARIS and Zachary MUNN. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evidence Synthesis. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2023, vol. 21, No 3, p. 494-506. ISSN 2689-8381. Available from: https://dx.doi.org/10.11124/JBIES-22-00430.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials
Authors BARKER, Timothy Hugh (guarantor), Jennifer C STONE, Kim SEARS, Miloslav KLUGAR (203 Czech Republic, belonging to the institution), Catalin TUFANARU, Jo LEONARDI-BEE, Edoardo AROMATARIS and Zachary MUNN.
Edition JBI Evidence Synthesis, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2023, 2689-8381.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30230 Other clinical medicine subjects
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.700 in 2022
RIV identification code RIV/00216224:14110/23:00130598
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.11124/JBIES-22-00430
UT WoS 000945987900005
Keywords in English critical appraisal tool; methodological quality; methodology; randomized controlled trial; risk of bias
Tags 14119612, 14119613, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 17/4/2023 10:20.
Abstract
JBI recently began the process of updating and revising its suite of critical appraisal tools to ensure that these tools remain compatible with recent developments within risk of bias science. Following a rigorous development process led by the JBI Effectiveness Methodology Group, this paper presents the revised critical appraisal tool for the assessment of risk of bias for randomized controlled trials. This paper also presents practical guidance on how the questions of this tool are to be interpreted and applied by systematic reviewers, while providing topical examples. We also discuss the major changes made to this tool compared to the previous version and justification for why these changes facilitate best-practice methodologies in this field.
Links
LTC20031, research and development projectName: Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic
Investor: Ministry of Education, Youth and Sports of the CR, INTER-COST
PrintDisplayed: 28/7/2024 19:26